Device Trial Radar · NCT07824583
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Jul 31, 2026
Primary completion
Feb 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Varian, a Siemens Healthineers CompanyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 17, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering radiation in shorter treatment time and better patient tolerance, with less breath holding.
Conditions
- Lung Cancer (Diagnosis)
- Liver Cancer, Adult
- Pancreatic Cancer
- Thoracic Cancers
- Abdominal Cancer
Interventions
Next Generation Delivery System (NGDS)Device
Participant will receive a "mock" treatment on the NGDS machine. Participant will complete experience questionnaires.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the feasibility of the mock NGDS DMAT workflow under breath hold conditions.Time frame: From enrollment to end of "mock" treatment of last participant enrolled, assessed up to 6 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Siteman Cancer Center Washington University
St Louis, Missouri · Recruiting
University Hospital Cleveland Medical Center
Cleveland, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.